Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR
Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR
Active, not recruiting · NCT05295628 · Registry updated 2025-08-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve insufficiency, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Active, not recruiting | Not applicable | 2025-08-06 | NCT05295628 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Emblok, Inc. | 2 |
| Yale Cardiovascular Research Group | 11 |
23 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.